D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$549M |
| 2 |
CVS Health
CVS
|
+$537M |
| 3 |
Meta Platforms (Facebook)
META
|
+$515M |
| 4 |
McDonald's
MCD
|
+$386M |
| 5 |
Home Depot
HD
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$475M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$442M |
| 3 |
AGN
Allergan plc
AGN
|
+$435M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$369M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.4% |
| 2 | Consumer Discretionary | 10.14% |
| 3 | Technology | 10.06% |
| 4 | Financials | 9.8% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPIL
3001
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $292K | ﹤0.01% |
38,141
-264,297
| -87% | -$2M |
|
|
SCMP
3002
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $292K | ﹤0.01% |
26,647
-51,444
| -66% | -$576K |
|
3003
Immunic
IMUX
$182M
| $289K | ﹤0.01% |
117
+29
| +33% | +$95.3K |
|
|
SQNM
3004
DELISTED
SEQUENOM INC NEW
SQNM
| $289K | ﹤0.01% |
316,438
-204,546
| -39% | -$244K |
|
|
ADVM
3005
DELISTED
Adverum Biotechnologies
ADVM
| $288K | ﹤0.01% |
+9,121
| New | +$412K |
|
3006
LendingTree
TREE
$544M
| $288K | ﹤0.01% |
+3,265
| New | +$277K |
|
|
AGR
3007
DELISTED
Avangrid, Inc.
AGR
| $288K | ﹤0.01% |
+6,245
| New | +$257K |
|
|
ARAV
3008
DELISTED
Aravive, Inc. Common Stock
ARAV
| $288K | ﹤0.01% |
4,342
-1,694
| -28% | -$96.3K |
|
|
GBL
3009
DELISTED
GAMCO Investors, Inc.
GBL
| $288K | ﹤0.01% |
+8,778
| New | +$321K |
|
3010
Ameresco
AMRC
$1.15B
| $287K | ﹤0.01% |
65,671
+53,614
| +445% | +$244K |
|
|
HIMX
3011
Himax Technologies
HIMX
$2.2B
| $287K | ﹤0.01% |
34,781
-51,520
| -60% | -$508K |
|
|
GNBC
3012
DELISTED
Green Bancorp, Inc
GNBC
| $286K | ﹤0.01% |
32,824
-383
| -1% | -$3.1K |
|
3013
American States Water
AWR
$3.39B
| $284K | ﹤0.01% |
+6,473
| New | +$261K |
|
3014
Camden National
CAC
$924M
| $284K | ﹤0.01% |
10,157
+1,269
| +14% | +$36K |
|
3015
Tyson Foods
TSN
$20.2B
| $283K | ﹤0.01% |
4,231
-347,874
| -99% | -$22.6M |
|
3016
UBS Group
UBS
$170B
| $283K | ﹤0.01% |
21,805
+1,960
| +10% | +$29.9K |
|
3017
Ocular Therapeutix
OCUL
$1.86B
| $282K | ﹤0.01% |
56,887
-32,843
| -37% | -$325K |
|
3018
Tonix Pharmaceuticals
TNXP
$157M
| – | – |
0
| – | – |
|
|
TEN
3019
Tsakos Energy Navigation Ltd
TEN
$1.19B
| $282K | ﹤0.01% |
12,034
+10,025
| +499% | +$295K |
|
|
LTS
3020
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $282K | ﹤0.01% |
119,498
+20,685
| +21% | +$52.1K |
|
|
AMRI
3021
DELISTED
Albany Molecular Research Inc
AMRI
| $282K | ﹤0.01% |
20,959
-59,659
| -74% | -$870K |
|
|
EMKR
3022
DELISTED
Emcore Corp
EMKR
| $282K | ﹤0.01% |
4,748
-16,147
| -77% | -$910K |
|
3023
Casey's General Stores
CASY
$31.9B
| $281K | ﹤0.01% |
+2,135
| New | +$248K |
|
3024
PUT
Chord Energy
CHRD
$7.79B
| $280K | ﹤0.01% |
30,000
| – | – |
|
3025
PUT
3M
MMM
$89B
| $280K | ﹤0.01% |
1,914
| – | – |
|
Similar funds
D.E. Shaw & Co's Q2 2016 Portfolio in Review
As of Q2 2016, D.E. Shaw & Co held 3,766 positions worth $54.2B, down 2.7% from $55.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $2.46B in Q2 2016, closing 445 positions and reducing 1,324 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $369M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in Liberty Media Corporation Series C Liberty SiriusXM Common Stock worth $198M.
- D.E. Shaw & Co's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 8,430,023 shares worth $198M.
- D.E. Shaw & Co added most to Amazon in Q2 2016, an estimated $549M increase.
- D.E. Shaw & Co's biggest Q2 2016 reduction was Booking.com, cutting an estimated $475M.
- D.E. Shaw & Co fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $369M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $54.2B portfolio in Q2 2016.
- D.E. Shaw & Co opened 402 new positions and closed 445 in Q2 2016.
- D.E. Shaw & Co's portfolio value fell 2.7% quarter-over-quarter to $54.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.